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COMMENTS ON RECENT MEETINGS 
Prostaglandins and Cyclic N ucleotides- Derma to logic Aspects 
On September 24, 1976, the first of a series of 
planned workshops, sponsored by the European 
Society for Dermatological Research, was held in 
Copenhagen. A small group of active European 
and American researchers met to discuss recent 
progress and future developments within the rap-
idly expanding field of prostaglandin and cyclic 
nucleotide research related to dermatology. 
The meeting covered a wide variety of topics 
including short introductory comments and infor-
mal discussions of technical problems related to 
measurement of prostaglandins (PG) and metabo-
lites in the arachidonate cascade and cyclic nucleo-
tides, animal model studies, and potential applica-
tion of achieved bask knowledge in human skin 
diseases. 
The recent discoveries of HETE (12-L-hydroxy-
5.8,10,14-eicosa tetraenoic acid) and the thrombox-
anes A2 and B~ will pose new challenges and deter-
minations of these substances and the endoperox-
ids (PGG2 and PGH2 ) and their metabolities will 
be required to delineate the role of this system in 
the skin. Gas chromatography and mass spectrom-
etry, discussed by Greaves (London), Goldy ne 
(Stockholm). and Hensby (London) give a compre-
hensive picture and are of especial value in the 
accurate identification and measurement of the 
very small amounts of prostaglandin-like agents 
found in skin. However, demonstration of biologic 
activity remains of central importance. Radioim-
munoassay procedures for the determination of 
several arachidonic acid metabolities are s till im-
proving, but uncertainty of the roles of different 
prostaglandins in given s ituations and lack of 
specificity still limit the general appHcability of 
these methods. 
Essential fatty acid (EF A)-deficient rats were 
used as a model by Ziboh <Miamil and Prottey 
(Wirral Merseyside). Ziboh reported on enzymatic 
transformation of PGE2 into PGF2,, by NADPH-
dependent PGE2-9-ketoreductase. An increased 
conversion into PGF2., was demonstrated in EFA-
deficient rats and in skin specimens from psoriatic 
plaques, and he suggested a possible role of PGF1 .. 
in the skin hyperproliferative process. The data on 
EF A-deficient rats presented by Prottey indicate 
that linoleic acid plays a specific role in the main-
tenance of the cutaneous barrier to insensible wa-
ter loss whereas arachidonic acid mainly seems 
involved in the control of skin scaliness. Youlten 
(London) presented data on cellular aspects of in-
flammation and found important species varia-
tions in the chemotactic action of prostaglandins 
in vitro on polymorphonuclear leukocytes which 
make it difficult to draw conclusions on the chemo-
tactic activity of prostaglandins in vivo. 
Modulation of cellular responses particularly 
those of immunologic nature were further dis-
cussed by Goldyne. The prostglandins appear to 
exert these effects through changes in the intracel-
lular ratio of the cyclic nucleotides: cAMP and 
cGMP. Voorhees (Michigan) reported on altera-
tion in the cyclic nucleotide systems and the ar-
achidonate cascade in the psoriasis lesions. In in-
volved psoriatic skin there is a marked increase in 
the concentration of free arachidonate and RETE 
as compared with uninvolved epidermis. The ratio 
of E and F prostaglandins may be of importance 
and several of the other metabolities in the arachi-
donate cascade may also interfere with cyclic nu-
cleotide metabolism in psoriasis. Marks (Cardiff) 
repor ted that intradermal injection of PGE 1 in 
guinea-pig skin, results in an increased labeling 
index. Furthermore, the increased epidermal 
thickness and labeling over dermal carrageenan 
granulomata could be blocked by indomethacin, 
aspirin, and polyphloretin phosphate. His data 
support the concept that E prostagla ndins may be 
responsible for the increased epidermopoiesis seen 
in a number of inflammatory skin disorders. When 
intracutaneously injected PGE~ caused a two-
phase vascular response, according to Hagermark 
<Stockholm) the initial phase was associated with 
itch and could be inhibited by antihistamine, and 
PGE2 was furthermore found to enhance the proin-
flammatory and pruritogenic effects of other 
agents. 
Biochemical and morphologic cyclic nucleotide 
receptor studies were reported by Nistrup (Copen-
hagen) and Orfanos (Cologne). Changes in recep-
tor functions could be induced by the action of 
''permissive" hormones. Thus. Nistrup showed 
that treatment with triiodothyronine increased 
the number of glucagon receptors in rat fat cells 
and this increase was paralelled by an increase in 
the formation of cAMP and glycerol after exposure 
of the cells to glucagon. In a study on membrane 
receptor sites, Orfanos reported that particularly 
PGF1., might change the cAMP-cGMP ratio and 
initiate DNA synthesis and suggested that the 
PG-cyclic nucleotide system may act as control 
mechanisms of epithelial tissues: the PGE/PGF 
balance affecting the extracellular receptor sites 
and the cAMP/cGMP ratio the intracellular mi-
lieu. 
A second workshop on prostaglandins and cydic 
nucleotides is planned for May 1978. 
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